Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33


Diagnosis of Tuberculosis Using Gastric Aspirates in Pediatric Patients in Haiti.

Pierre-Louis MH, Rouzier V, Rivera V, Systrom HK, Julma P, Jean E, Francois LC, Pape JW, Ocheretina O, Wright PF.

J Pediatric Infect Dis Soc. 2020 Feb 24. pii: piaa012. doi: 10.1093/jpids/piaa012. [Epub ahead of print]


Early bactericidal activity trial of nitazoxanide for pulmonary tuberculosis.

Walsh KF, McAulay K, Lee MH, Vilbrun SC, Mathurin L, Francois DJ, Zimmerman M, Kaya F, Zhang N, Saito K, Ocheretina O, Savic R, Dartois V, Johnson WD, Pape JW, Nathan C, Fitzgerald DW.

Antimicrob Agents Chemother. 2020 Feb 18. pii: AAC.01956-19. doi: 10.1128/AAC.01956-19. [Epub ahead of print]


Diagnostic yield of active case finding for tuberculosis at human immunodeficiency virus testing in Haiti.

Rivera VR, Lu L, Ocheretina O, Jean Juste MA, Julma P, Archange D, Moise CG, Homeus F, Phanor PD, Petión S, Cremieux PY, Fitzgerald DW, Pape JW, Koenig SP.

Int J Tuberc Lung Dis. 2019 Nov 1;23(11):1217-1222. doi: 10.5588/ijtld.18.0835.


Improved Outcomes With High-dose Isoniazid in Multidrug-resistant Tuberculosis Treatment in Haiti.

Walsh KF, Vilbrun SC, Souroutzidis A, Delva S, Joissaint G, Mathurin L, Ocheretina O, Cremieux P, Pape JW, Koenig SP.

Clin Infect Dis. 2019 Aug 1;69(4):717-719. doi: 10.1093/cid/ciz039.


Differentially Detectable Mycobacterium tuberculosis Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment.

McAulay K, Saito K, Warrier T, Walsh KF, Mathurin LD, Royal-Mardi G, Lee MH, Ocheretina O, Pape JW, Fitzgerald DW, Nathan CF.

mBio. 2018 Nov 20;9(6). pii: e02192-18. doi: 10.1128/mBio.02192-18.


Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania.

Kidenya BR, Mshana SE, Fitzgerald DW, Ocheretina O.

Tuberculosis (Edinb). 2018 Mar;109:97-101. doi: 10.1016/ Epub 2018 Feb 21.


Diagnostic yield of active case finding for tuberculosis and HIV at the household level in slums in Haiti.

Rivera VR, Jean-Juste MA, Gluck SC, Reeder HT, Sainristil J, Julma P, Peck M, Joseph P, Ocheretina O, Perodin C, Secours R, Duran-Mendicuti M, Hashiguchi L, Cremieux PY, Koenig SP, Pape JW.

Int J Tuberc Lung Dis. 2017 Nov 1;21(11):1140-1146. doi: 10.5588/ijtld.17.0049.


Active Tuberculosis Case Finding in Haiti.

Masur J, Koenig SP, Julma P, Ocheretina O, Durán-Mendicuti MA, Fitzgerald DW, Pape JW.

Am J Trop Med Hyg. 2017 Aug;97(2):433-435. doi: 10.4269/ajtmh.16-0674. Epub 2017 Jul 19.


Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis screening and treatment of pregnant women in Port-au-Prince, Haiti.

Bristow CC, Mathelier P, Ocheretina O, Benoit D, Pape JW, Wynn A, Klausner JD.

Int J STD AIDS. 2017 Oct;28(11):1130-1134. doi: 10.1177/0956462416689755. Epub 2017 Jan 29.


Clinical Features of Human Immunodeficiency Virus-Infected Patients Presenting with Cholera in Port-au-Prince, Haiti.

Sévère K, Anglade SB, Bertil C, Duncan A, Joseph P, Deroncenay A, Mabou MM, Ocheretina O, Reif L, Seo G, Pape JW, Fitzgerald DW.

Am J Trop Med Hyg. 2016 Nov 2;95(5):999-1003. Epub 2016 Aug 22.


False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load.

Ocheretina O, Byrt E, Mabou MM, Royal-Mardi G, Merveille YM, Rouzier V, Fitzgerald DW, Pape JW.

Diagn Microbiol Infect Dis. 2016 May;85(1):53-5. doi: 10.1016/j.diagmicrobio.2016.01.009. Epub 2016 Jan 15.


Tuberculosis in the aftermath of the 2010 earthquake in Haiti.

Koenig SP, Rouzier V, Vilbrun SC, Morose W, Collins SE, Joseph P, Decome D, Ocheretina O, Galbaud S, Hashiguchi L, Pierrot J, Pape JW.

Bull World Health Organ. 2015 Jul 1;93(7):498-502. doi: 10.2471/BLT.14.145649. Epub 2015 May 1.


Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.

Ocheretina O, Shen L, Escuyer VE, Mabou MM, Royal-Mardi G, Collins SE, Pape JW, Fitzgerald DW.

PLoS One. 2015 Jun 3;10(6):e0129207. doi: 10.1371/journal.pone.0129207. eCollection 2015.


CD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001.

Collins SE, Jean Juste MA, Koenig SP, Secours R, Ocheretina O, Bernard D, Riviere C, Calnan M, Dunning A, Hurtado Rúa SM, Johnson WD Jr, Pape JW, Fitzgerald DW, Severe P.

Int J Tuberc Lung Dis. 2015 Jan;19(1):50-7. doi: 10.5588/ijtld.14.0217.


High-throughput mycobacterial interspersed repetitive-unit-variable-number tandem-repeat genotyping for Mycobacterium tuberculosis epidemiological studies.

Gauthier M, Bidault F, Mosnier A, Bablishvili N, Tukvadze N, Somphavong S, Paboriboune P, Ocheretina O, Pape JW, Paranhos-Baccala G, Berland JL.

J Clin Microbiol. 2015 Feb;53(2):498-503. doi: 10.1128/JCM.01611-14. Epub 2014 Nov 26.


Treatment outcomes for patients with multidrug-resistant tuberculosis in post-earthquake Port-au-Prince, Haiti.

Charles M, Vilbrun SC, Koenig SP, Hashiguchi LM, Mabou MM, Ocheretina O, Pape JW.

Am J Trop Med Hyg. 2014 Oct;91(4):715-21. doi: 10.4269/ajtmh.14-0161. Epub 2014 Jul 28.


A multiplex PCR/LDR assay for simultaneous detection and identification of the NIAID category B bacterial food and water-borne pathogens.

Rundell MS, Pingle M, Das S, Hussain A, Ocheretina O, Charles M, Larone DH, Spitzer ED, Golightly L, Barany F.

Diagn Microbiol Infect Dis. 2014 Jun;79(2):135-40. doi: 10.1016/j.diagmicrobio.2014.02.022. Epub 2014 Mar 12.


Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results.

Ocheretina O, Escuyer VE, Mabou MM, Royal-Mardi G, Collins S, Vilbrun SC, Pape JW, Fitzgerald DW.

PLoS One. 2014 Mar 5;9(3):e90569. doi: 10.1371/journal.pone.0090569. eCollection 2014.


Stepwise implementation of a new diagnostic algorithm for multidrug-resistant tuberculosis in Haiti.

Gauthier M, Somoskövi A, Berland JL, Ocheretina O, Mabou MM, Boncy J, Gutierrez C, Vernet G, Pape JW.

Int J Tuberc Lung Dis. 2014 Feb;18(2):220-6. doi: 10.5588/ijtld.13.0513.


The aetiology of vaginal symptoms in rural Haiti.

Bristow CC, Desgrottes T, Cutler L, Cutler D, Devarajan K, Ocheretina O, Pape JW, Klausner JD.

Int J STD AIDS. 2014 Aug;25(9):669-75. doi: 10.1177/0956462413516300. Epub 2013 Dec 18.


Epidemiology and genetic diversity of multidrug-resistant tuberculosis in East Africa.

Kidenya BR, Webster LE, Behan S, Kabangila R, Peck RN, Mshana SE, Ocheretina O, Fitzgerald DW.

Tuberculosis (Edinb). 2014 Jan;94(1):1-7. doi: 10.1016/ Epub 2013 Sep 7. Review.


Use of Luminex MagPlex magnetic microspheres for high-throughput spoligotyping of Mycobacterium tuberculosis isolates in Port-au-Prince, Haiti.

Ocheretina O, Merveille YM, Mabou MM, Escuyer VE, Dunbar SA, Johnson WD, Pape JW, Fitzgerald DW.

J Clin Microbiol. 2013 Jul;51(7):2232-7. doi: 10.1128/JCM.00268-13. Epub 2013 May 8.


Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.

Shigyo K, Ocheretina O, Merveille YM, Johnson WD, Pape JW, Nathan CF, Fitzgerald DW.

Antimicrob Agents Chemother. 2013 Jun;57(6):2834-7. doi: 10.1128/AAC.02542-12. Epub 2013 Mar 18.


Multidrug-resistant tuberculosis in Port-au-Prince, Haiti.

Ocheretina O, Morose W, Gauthier M, Joseph P, D'Meza R, Escuyer VE, Rastogi N, Vernet G, Pape JW, Fitzgerald DW.

Rev Panam Salud Publica. 2012 Mar;31(3):221-4.


The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E2 levels.

Fitzgerald DW, Bezak K, Ocheretina O, Riviere C, Wright TC, Milne GL, Zhou XK, Du B, Subbaramaiah K, Byrt E, Goodwin ML, Rafii A, Dannenberg AJ.

Cancer Prev Res (Phila). 2012 Jan;5(1):34-40. doi: 10.1158/1940-6207.CAPR-11-0496. Epub 2011 Dec 1.


Adenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling.

Nociari M, Ocheretina O, Murphy M, Falck-Pedersen E.

J Virol. 2009 May;83(9):4081-91. doi: 10.1128/JVI.02591-08. Epub 2009 Feb 11.


Light-modulated NADP-malate dehydrogenases from mossfern and green algae: insights into evolution of the enzyme's regulation.

Ocheretina O, Haferkamp I, Tellioglu H, Scheibe R.

Gene. 2000 Nov 27;258(1-2):147-54.


A novel, non-redox-regulated NAD-dependent malate dehydrogenase from chloroplasts of Arabidopsis thaliana L.

Berkemeyer M, Scheibe R, Ocheretina O.

J Biol Chem. 1998 Oct 23;273(43):27927-33.


Cloning and sequence analysis of cDNAs encoding plant cytosolic malate dehydrogenase.

Ocheretina O, Scheibe R.

Gene. 1997 Oct 15;199(1-2):145-8.


Redox equilibria between the regulatory thiols of light/dark-modulated chloroplast enzymes and dithiothreitol: fine-tuning by metabolites.

Faske M, Holtgrefe S, Ocheretina O, Meister M, Backhausen JE, Scheibe R.

Biochim Biophys Acta. 1995 Feb 22;1247(1):135-42.


Cysteines of chloroplast NADP-malate dehydrogenase form mixed disulfides.

Ocheretina O, Scheibe R.

FEBS Lett. 1994 Dec 5;355(3):254-8.


Effects of N-terminal truncations upon chloroplast NADP-malate dehydrogenases from pea and spinach.

Ocheretina O, Harnecker J, Rother T, Schmid R, Scheibe R.

Biochim Biophys Acta. 1993 Apr 21;1163(1):10-6.


Supplemental Content

Loading ...
Support Center